tiprankstipranks
Trending News
More News >
DANONE SA (FR:BN)
:BN

DANONE SA (BN) AI Stock Analysis

Compare
52 Followers

Top Page

FR

DANONE SA

(LSE:BN)

Rating:61Neutral
Price Target:
€74.00
▲(6.47%Upside)
Danone SA's strong financial performance, marked by improved profitability and reduced leverage, is a positive factor. However, bearish technical indicators and a fair valuation limit the stock's attractiveness. The absence of earnings call data and corporate events means these are not factors in this evaluation.
Positive Factors
Earnings
Danone is expected to achieve close to 5% organic growth this year, placing it at the high-end of its long-term growth algorithm.
Health Trends
Danone is well-positioned to benefit from increasing consumers' focus on health and favorable demographic trends.
Market Position
Danone Aptamil holds a significant market share at 14% in the China IMF market.
Negative Factors
Competition
North America volume/mix slowed as Danone's International Delight brand faced increased competition as well as some product recalls due to texture issues.
Margin Risk
A potential RMB1bn subsidy would suggest a 10-20bps impact on group margins.
Market Challenges
Challenges into the second quarter could get more pronounced.

DANONE SA (BN) vs. iShares MSCI France ETF (EWQ)

DANONE SA Business Overview & Revenue Model

Company DescriptionDanone S.A. is a multinational food-products corporation headquartered in Paris, France. It operates in three primary sectors: Essential Dairy and Plant-Based Products, Specialized Nutrition, and Waters. Danone's core products include yogurt, plant-based foods and beverages, infant nutrition, medical nutrition, and bottled water, with well-known brands like Activia, Actimel, Alpro, Aptamil, and Evian under its portfolio. The company is committed to promoting health through food to as many people as possible, leveraging its global presence and diverse product range.
How the Company Makes MoneyDanone S.A. generates revenue through the sale of its diverse range of food and beverage products across its three main sectors. The Essential Dairy and Plant-Based Products segment, which includes yogurt and plant-based alternatives, is a significant contributor to its revenue, leveraging brands like Activia and Alpro. The Specialized Nutrition sector, comprising infant and medical nutrition products, is another key revenue stream, with brands such as Aptamil and Nutricia. The Waters segment, featuring brands like Evian and Volvic, contributes to the company's earnings through the sale of bottled water. Danone's revenue model is supported by its global distribution network, strategic acquisitions, and partnerships that enhance its market reach and product offerings. The company's focus on health and sustainability also plays a crucial role in its business strategy and consumer appeal.

DANONE SA Financial Statement Overview

Summary
Danone SA exhibits strong financial health with improving profitability and reduced leverage. The company maintains consistent cash generation, supporting its operational and strategic initiatives. While revenue growth remains a challenge, the firm's solid balance sheet and cash flow position it well in the competitive consumer products industry.
Income Statement
75
Positive
Danone SA shows a stable gross profit margin with a consistent EBIT and EBITDA margin over the years. The net profit margin improved significantly in 2024 compared to 2023, indicating enhanced profitability. However, revenue growth has been stagnant, reflecting competitive industry pressures.
Balance Sheet
80
Positive
The company's balance sheet reflects strong equity figures, with a notable reduction in total debt by 2024, resulting in a debt-to-equity ratio of 0. This indicates prudent financial management and reduced leverage risk. The equity ratio has remained stable, showcasing a solid financial foundation.
Cash Flow
78
Positive
Danone demonstrates robust free cash flow generation with positive growth in free cash flow from 2023 to 2024. The operating cash flow to net income ratio indicates efficient cash generation relative to earnings. However, fluctuations in investing and financing cash flows suggest potential volatility in capital allocation strategies.
BreakdownDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue27.38B27.62B27.66B24.28B23.62B
Gross Profit13.61B13.08B12.74B11.52B11.35B
EBITDA4.77B3.81B4.00B3.58B4.30B
Net Income2.02B881.00M959.00M1.92B1.96B
Balance Sheet
Total Assets45.29B44.49B45.28B45.42B42.78B
Cash, Cash Equivalents and Short-Term Investments6.16B6.00B4.68B5.86B4.27B
Total Debt14.80B15.60B14.16B16.59B16.50B
Total Liabilities27.44B28.26B27.29B28.05B26.48B
Stockholders Equity17.80B16.18B17.92B17.27B16.20B
Cash Flow
Free Cash Flow2.91B2.60B2.09B2.43B2.00B
Operating Cash Flow3.83B3.44B2.96B3.47B2.97B
Investing Cash Flow-463.00M-834.00M-749.00M561.00M-610.00M
Financing Cash Flow-3.82B-1.94B-1.93B-4.03B-2.27B

DANONE SA Technical Analysis

Technical Analysis Sentiment
Negative
Last Price69.50
Price Trends
50DMA
73.35
Negative
100DMA
70.66
Negative
200DMA
66.97
Positive
Market Momentum
MACD
-1.02
Positive
RSI
24.32
Positive
STOCH
8.20
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For FR:BN, the sentiment is Negative. The current price of 69.5 is below the 20-day moving average (MA) of 72.48, below the 50-day MA of 73.35, and above the 200-day MA of 66.97, indicating a neutral trend. The MACD of -1.02 indicates Positive momentum. The RSI at 24.32 is Positive, neither overbought nor oversold. The STOCH value of 8.20 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for FR:BN.

DANONE SA Peers Comparison

Overall Rating
UnderperformOutperform
Sector (65)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
65
Neutral
$26.91B15.06-4.01%3.23%1.02%2.12%
63
Neutral
€839.36M7.656.45%2.27%5.14%11.66%
FRBN
61
Neutral
€45.02B22.2411.87%2.67%-0.88%129.97%
60
Neutral
€2.47B37.01
0.76%2.58%-21.50%
FRBON
50
Neutral
€269.79M-15.69%2.33%-4.12%-13922.22%
* Consumer Defensive Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
FR:BN
DANONE SA
69.50
14.02
25.26%
FR:SAVE
Savencia
63.00
13.30
26.75%
FR:BON
Bonduelle
8.48
2.58
43.80%
FR:UNBL
UNIBEL SA
1,180.00
330.00
38.82%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Jun 26, 2025